Safety and Patient Acceptability of BXCL501 for Treating Acute Agitation in Patients With Bipolar Disorder
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
2021
Journal Title
Bipolar Disorders
Department
Psychiatry and Behavioral Sciences
Recommended Citation
Zeller, S., Citrome, L., Goldberg, J., Finman, J., De Vivo, M., Yocca, F., & Risinger, R. (2021). Safety and Patient Acceptability of BXCL501 for Treating Acute Agitation in Patients With Bipolar Disorder. Bipolar Disorders, 23 (Suppl. 1), 61-62. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/529
COinS
